Scientific Reviews
Product Guides
Blogs
Topics
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!2025-02-06
14 Results for "
TMPRSS6
" in MedChemExpress (MCE) Product Catalog:
Products (14)
14 Results for "TMPRSS6" in MCE Product Catalog:
Referencia número: HY-177662
No. CAS: 2273007-95-5
Synonyms: IONIS-TMPRSS6-Lrx; ISIS 702843
Target:
Áreas de investigación:
Sapablursen, an antisense oligonucleotide, is designed to reduce the production of TMPRSS6 resulting in increased expression of hepcidin, which is the key regulator of iron homeostasis. Sapablursen can be used in the research of blood diseases such as pol
Referencia número: HY-130136A
Target:
Áreas de investigación:
TMPRSS6-IN-1 (TFA) is a potent inhibitor of TMPRSS6 (Matriptase-2), belonging to TTSPs (transmembrane serine protease). TMPRSS6, is a type II TTSP, the genetic reduction of which will improve symptoms of hemochromatosis and beta thalassemia in mice .
Referencia número: HY-130136
No. CAS: 2088415-78-3
Target:
Áreas de investigación:
TMPRSS6-IN-1 (compound 8) is a potent inhibitor of TMPRSS6 (Matriptase-2), belonging to TTSPs (transmembrane serine protease). TMPRSS6, is a type II TTSP, the genetic reduction of which will improve symptoms of hemochromatosis and beta thalassemia in mice .
Referencia número: HY-147278
No. CAS: 2646704-10-9
Synonyms: Divesiran; SLN124
Áreas de investigación:
Manusiran (Divesiran) is a GalNac-siRNA targeting liver and transmembrane serine protease 6 (Serine protease 6). Manusiran increases hepatic Hepcidin synthesis and plasma levels by silencing TMPRSS6, a negative regulator of hepcidin production, and limits the availability of iron required for erythropoiesis. Combined use of Manusiran with Deferiprone (HY-B0568) reduces ineffective erythropoiesis and hepatic iron overload in a mouse model of β-thalassemia. Manusiran can be used for research on polycythemia vera, type 1 hereditary hemochromatosis, and β-thalassemia .
Referencia número: HY-177662A
No. CAS: 2273008-00-5
Synonyms: IONIS-TMPRSS6-Lrx sodium; ISIS 702843 sodium
Target:
Áreas de investigación:
Sapablursen sodium, an antisense oligonucleotide, is designed to reduce the production of TMPRSS6 resulting in increased expression of hepcidin, which is the key regulator of iron homeostasis. Sapablursen sodium can be used in the research of blood diseas
Referencia número: HY-RS19286
Target:
Áreas de investigación:
Tmprss6 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Tmprss6 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.
Referencia número: HY-P11260
No. CAS: 3051556-89-6
Target:
Áreas de investigación:
Referencia número: HY-RS14773
Target:
Áreas de investigación:
TMPRSS6 Human Pre-designed siRNA Set A contains three designed siRNAs for TMPRSS6 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
Referencia número: HY-RS25776
Target:
Áreas de investigación:
Tmprss6 Rat Pre-designed siRNA Set A contains three designed siRNAs for Tmprss6 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.
Referencia número: HY-147278A
Synonyms: Divesiran sodium; SLN124 sodium
Áreas de investigación:
Manusiran sodium (Divesiran sodium) is a GalNac-siRNA targeting liver and transmembrane serine protease 6 (Serine protease 6). Manusiran sodium increases hepatic Hepcidin synthesis and plasma levels by silencing TMPRSS6, a negative regulator of hepcidin production, and limits the availability of iron required for erythropoiesis. Combined use of Manusiran sodium with Deferiprone (HY-B0568) reduces ineffective erythropoiesis and hepatic iron overload in a mouse model of β-thalassemia. Manusiran sodium can be used for research on polycythemia vera, type 1 hereditary hemochromatosis, and β-thalassemia .
Referencia número: HY-P991637
No. CAS: 2996101-49-4
Synonyms: REGN7999
Target:
Áreas de investigación:
Referencia número: HY-180217
Áreas de investigación:
WGU55 is a selective and potent reversible type II transmembrane serine protease TMPRSS6 inhibitor with a Ki of 12.15 nM. WGU55 inhibits TMPRSS6 activity with an IC50 of 138 nMin KEK293 cells. WGU55 has a Ki of 3510 nM (SI = 289) against the homologous protease matriptase and a Ki of 5.2 μM against the coagulation key protease Factor Xa. WGU55 can be used for the research of iron overload related diseases, such as hereditary hemochromatosis .
Referencia número: HY-P992451
Synonyms: KY1066
Áreas de investigación:
- 1
-
-
Protocols
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!A suitable model is crucial in drug screening experiments. Organs can mimic the three-dimensional functional structure of internal organs, have similar spatial organization to corresponding organs, maintain some key characteristics, and reproduce some physiological functions. They are widely used for modeling and personalized drug screening physiological functions.2025-02-06
